The Agreement allows HAVN Life to export naturally derived psilocybin from its Jamaica facility and grows roster of supply partners in the U.S. market VANCOUVER, BC, Feb. 10, 2022 /CNW/ – HAVN Life Sciences Inc.(CSE: HAVN) (OTC: HAVLF) (FSE: 5NP)(the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential…
